Elevated non-high-density lipoprotein cholesterol corresponds to a high risk of nephrolithiasis in children

Meiyuan Chen1, Jing Xiao2, Yuan Du2

  • 1Department of Urology, Beijing Friendship Hospital Affiliated to the Capital Medical University, No. 95, Yong'an Road, Xicheng District, Beijing, 100050, China. Meiyuan.chen@gmail.com.

BMC Urology
|August 12, 2020
PubMed

Insights

In children, elevated non-high-density lipoprotein cholesterol (non-HDL-c) and serum uric acid are linked to urolithiasis. Non-HDL-c may be a key lipid risk factor for pediatric kidney stones.

Area of Science:

  • Pediatric Nephrology
  • Metabolic Disorders
  • Urology

Background:

  • Dyslipidemia is a known risk factor for nephrolithiasis in adults.
  • The association between dyslipidemia and urolithiasis in children is not well-established.

Purpose of the Study:

  • To investigate the relationship between dyslipidemia and urolithiasis in pediatric patients.
  • To identify potential lipid risk factors for urolithiasis in children.

Main Methods:

  • A case-control study was conducted with 58 pediatric patients with upper urinary tract stones and 351 controls.
  • Comparisons included age, BMI, serum calcium, uric acid, glucose, blood lipids, and stone composition.

Main Results:

  • Children with urolithiasis had higher serum uric acid and non-high-density lipoprotein cholesterol (non-HDL-c).
  • Multivariate analysis confirmed non-HDL-c and serum uric acid as significant factors.
  • Non-HDL-c was associated with pure calcium oxalate stones.

Conclusions:

  • Non-high-density lipoprotein cholesterol (non-HDL-c) may be a significant lipid risk factor for urolithiasis in children.
  • Serum uric acid is also elevated in pediatric stone formers.
Abstract

Related Concept Videos

Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
276
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
367
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
313
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
420
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
127